LBPWQ

PINK:LBPWQ USA
Market Cap
$0.92
Market Cap Rank
#44094 Global
#14029 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$1.76
About

4D pharma plc, together with its subsidiaries, develops live biotherapeutic products (LBPs) in the United Kingdom. The company develops therapeutic candidates, including MRx0518 for the treatment of cancer and immune-oncology diseases; MRx-4DP0004 for the treatment of asthma; MRx0029 and MRx0005 the treatment of central nervous system disorders; Blautix for irritable bowel syndrome; and Thetanix … Read more

LBPWQ (LBPWQ) - Net Assets

Latest net assets as of : $- USD

Based on the latest financial reports, LBPWQ (LBPWQ) has net assets worth $- USD as of .

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($-) and total liabilities ($-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-
% of Total Assets 0%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

LBPWQ - Net Assets Trend (None–None)

This chart illustrates how LBPWQ's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for LBPWQ (None–None)

The table below shows the annual net assets of LBPWQ from None to None.

Year Net Assets Change
No yearly data available.

Equity Component Analysis

This analysis shows how different components contribute to LBPWQ's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • No equity composition insights available.

LBPWQ Competitors by Market Cap

The table below lists competitors of LBPWQ ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in LBPWQ's equity between the two most recent reporting periods.

Insufficient data available to analyze equity growth attribution.

Book Value vs Market Value Analysis

This analysis compares LBPWQ's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Insufficient data available to analyze book value vs market value.

Capital Efficiency Dashboard

This dashboard shows how efficiently LBPWQ utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Insufficient data available to analyze capital efficiency metrics.

Industry Comparison

This section compares LBPWQ's net assets metrics with peer companies in the same industry.

Industry Context

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
LBPWQ (LBPWQ) $- N/A N/A $17.20K
Abcam plc (ABCZF) $726.90 Million -1.17% 0.45x $5.00 Billion
Able View Global Inc. Warrant (ABLVW) $11.42 Million 85.41% 3.81x $277.93K
Above Food Ingredients Inc. Warrants (ABVEW) $199.86 Million -2.89% 0.00x $6.25 Million
Adamas Trust, Inc. (ADAMG) $2.43 Billion 7.94% 1.33x $2.09 Billion
ADS-TEC ENERGY PLC Warrant (ADSEW) $33.92 Million -162.39% 2.67x $10.06 Million
Alliance Entertainment Holding Corporation Warrants (AENTW) $52.92 Million 10.13% 4.23x $2.29 Million
Forafric Global PLC Warrants (AFRIW) $5.32 Million -457.58% 45.29x $2.67 Million
Centurion Acquisition Corp. Warrant (ALFUW) $282.84 Million 1.97% 0.05x $4.81 Million
Alliance Trust PLC (ALITF) $4.04 Billion 10.04% 0.29x $112.87K
Alvotech Warrant (ALVOW) $-564.42 Million 0.00% 0.00x $35.01 Million